State Street’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $636K | Buy |
275,392
+39,264
| +17% | +$90.7K | ﹤0.01% | 3573 |
|
|
2025
Q1 | $1.84M | Buy |
236,128
+9,700
| +4% | +$75.8K | ﹤0.01% | 3274 |
|
|
2024
Q4 | $1.06M | Hold |
226,428
| – | – | ﹤0.01% | 3482 |
|
|
2024
Q3 | $1.22M | Buy |
226,428
+58,838
| +35% | +$317K | ﹤0.01% | 3451 |
|
|
2024
Q2 | $1.48M | Buy |
167,590
+122,527
| +272% | +$1.08M | ﹤0.01% | 3412 |
|
|
2024
Q1 | $529K | Hold |
45,063
| – | – | ﹤0.01% | 3630 |
|
|
2023
Q4 | $507K | Buy |
45,063
+100
| +0.2% | +$1.13K | ﹤0.01% | 3638 |
|
|
2023
Q3 | $308K | Hold |
44,963
| – | – | ﹤0.01% | 3805 |
|
|
2023
Q2 | $408K | Hold |
44,963
| – | – | ﹤0.01% | 3743 |
|
|
2023
Q1 | $290K | Hold |
44,963
| – | – | ﹤0.01% | 3939 |
|
|
2022
Q4 | $285K | Hold |
44,963
| – | – | ﹤0.01% | 3968 |
|
|
2022
Q3 | $279K | Hold |
44,963
| – | – | ﹤0.01% | 3995 |
|
|
2022
Q2 | $397K | Buy |
44,963
+7,300
| +19% | +$64.5K | ﹤0.01% | 3927 |
|
|
2022
Q1 | $317K | Buy |
37,663
+3,847
| +11% | +$32.4K | ﹤0.01% | 4222 |
|
|
2021
Q4 | $345K | Buy |
33,816
+6,100
| +22% | +$62.2K | ﹤0.01% | 4142 |
|
|
2021
Q3 | $538K | Sell |
27,716
-7,100
| -20% | -$138K | ﹤0.01% | 3942 |
|
|
2021
Q2 | $612K | Buy |
+34,816
| New | +$612K | ﹤0.01% | 3791 |
|